Status:
RECRUITING
Patient Reported Outcomes for Vascular Malformations EmbolizatioN (PROVEN)
Lead Sponsor:
Johns Hopkins University
Conditions:
Vascular Malformations
VM - Vascular Malformation
Eligibility:
All Genders
Up to 100 years
Brief Summary
The purpose of this study is to develop a standardized assessment for patients treated for venous malformations (VM). Venous malformations result from the abnormal development of veins which may resu...
Eligibility Criteria
Inclusion
- Male and Female pediatric patients, aged between 0-17 with diagnosis of vascular malformations.
- Male and Female adult patients aged 18-100 with diagnosis of vascular malformations.
- Vascular malformation symptoms significant enough to seek treatment.
Exclusion
- Patients with extensive VM not suitable for sclerotherapy.
- Prior therapy for treatment of a VM within 3 months.
- Condition or impairment that may render the patient unable to take part in the study (e.g. cognitive, sight, hearing, etc.).
Key Trial Info
Start Date :
July 22 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2026
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04104464
Start Date
July 22 2019
End Date
July 1 2026
Last Update
August 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Johns Hopkins Hospital
Baltimore, Maryland, United States, 21287